Bml Capital Management, LLC / DSGN
Bml Capital Management, LLC’s Design Therapeutics Inc Position
Does Bml Capital Management, LLC own Design Therapeutics Inc (DSGN)? Not currently — the last reported position was 421.7K shares worth $1M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$1M
Q2 2024
Shares
421.7K
% of Portfolio
+1.01%
Quarters Held
3
position exited
Position History DSGN
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bml Capital Management, LLC’s full portfolio or all institutional holders of DSGN.